Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Terminated 31 enrolled Hillerod Hospital, Denmark Tvergaards Foundation · collab Wyeth is now a wholly owned subsidiary of Pfizer · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study investigates the hypothesis that pindolol can accelerate the response to antidepressants in patients with major depression treated with venlafaxine.

Timeline

Start: 2002-08
Primary completion: —
Completion: 2007-09

Publications

Martiny K, Lunde M, Bech P, Plenge P. A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression. Nord J Psychiatry. 2012 Jun;66(3):147-54. doi: 10.3109/08039488.2012.674553. Epub 2012 Mar 29.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pindolol	Small molecule	20 mg	—
Comparator	Venlafaxine	Small molecule	150 mg	—

Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Summary

Timeline

Publications

Drugs

Indications